Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DEBRISOQUINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 873 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Llerena, A; Berecz, R; Norberto, MJ; de la Rubia, A
      Determination of clozapine and its N-desmethyl metabolite by high-performance liquid chromatography with ultraviolet detection

      JOURNAL OF CHROMATOGRAPHY B
    2. Bendriss, EK; Markoglou, N; Wainer, IW
      High-performance liquid chromatography assay for simultaneous determination of dextromethorphan and its main metabolites in urine and in microsomal preparations

      JOURNAL OF CHROMATOGRAPHY B
    3. Ingelman-Sundberg, M
      Genetic susceptibility to adverse effects of drugs and environmental toxicants - The role of the CYP family of enzymes

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    4. Furuno, T; Kawanishi, C; Iseki, E; Onishi, H; Sugiyama, N; Suzuki, K; Kosaka, K
      No evidence of an association between CYP2D6 polymorphisms among Japanese and dementia with Lewy bodies

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    5. Wilson, JF; Weale, ME; Smith, AC; Gratrix, F; Fletcher, B; Thomas, MG; Bradman, N; Goldstein, DB
      Population genetic structure of variable drug response

      NATURE GENETICS
    6. Smith, G; Sachse, C
      A role for CYP2D6 in nicotine metabolism? Target article on nicotine-addiction

      PSYCOLOQUY
    7. Tsuzuki, D; Takemi, C; Yamamoto, S; Tamagake, K; Imaoka, S; Funae, Y; Kataoka, H; Shinoda, S; Narimatsu, S
      Functional evaluation of cytochrome P450 2D6 with Gly(42)Arg substitution expressed in Saccharomyces cerevisiae

      PHARMACOGENETICS
    8. Allorge, D; Harlow, J; Boulet, O; Hayhurst, GP; Chowdry, J; Roth, E; Crewe, K; Lo-Guidice, JM; Lhermitte, M; Broly, F; Tucker, GT; Ellis, SW
      In-vitro analysis of the contribution of CYP2D6.35 to ultrarapid metabolism

      PHARMACOGENETICS
    9. Zanger, UM; Fischer, J; Raimundo, S; Stuven, T; Evert, BO; Schwab, M; Eichelbaum, M
      Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6

      PHARMACOGENETICS
    10. Ramamoorthy, Y; Tyndale, RF; Sellers, EM
      Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates

      PHARMACOGENETICS
    11. Wan, YJY; Poland, RE; Han, G; Konishi, T; Zheng, YP; Berman, N; Lin, KM
      Analysis of the CYP2D6 gene polymorphism and enzyme activity in African-Americans in Southern California

      PHARMACOGENETICS
    12. Wennerholm, A; Johansson, I; Hidestrand, M; Bertilsson, L; Gustafsson, LL; Ingelman-Sundberg, M
      Characterization of the CYP2D6*29 allele commonly present in a blade Tanzanian population causing reduced catalytic activity

      PHARMACOGENETICS
    13. Siegle, I; Fritz, P; Eckhardt, K; Zanger, UM; Eichelbaum, M
      Cellular localization and regional distribution of CYP2D6 mRNA and proteinexpression in human brain

      PHARMACOGENETICS
    14. Shimada, T; Tsumura, F; Yamazaki, H; Guengerich, FP; Inoue, K
      Characterization of (+/-)-bufuralol hydroxylation activities in liver microsomes of Japanese and Caucasian subjects genotyped for CYP2D6

      PHARMACOGENETICS
    15. Lovlie, R; Daly, AK; Matre, GE; Molven, A; Steen, VM
      Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?

      PHARMACOGENETICS
    16. Griese, EU; Ilett, KF; Kitteringham, NR; Eichelbaum, M; Powell, H; Spargo, RM; LeSouef, PN; Musk, AW; Minchin, RF
      Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in Aborigines from Western Australia

      PHARMACOGENETICS
    17. Ingelman-Sundberg, M
      Pharmaco genetics: an opportunity for a safer and more efficient pharmacotherapy

      JOURNAL OF INTERNAL MEDICINE
    18. Brosen, K; Naranjo, CA
      Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    19. Yasui-Furukori, N; Kondo, T; Suzuki, A; Mihara, K; Tokinaga, N; Inoue, Y; Otani, K; Kaneko, S
      Effect of the CYP2D6 genotype on prolactin concentration in schizophrenic patients treated with haloperidol

      SCHIZOPHRENIA RESEARCH
    20. Narimatsu, S; Arai, T; Masubuchi, Y; Horie, T; Hosokawa, M; Ueno, K; Kataoka, H; Yamamoto, S; Ishikawa, T; Cho, AK
      Inactivation of rat cytochrome P450 2D enzyme by a further metabolite of 4-hydroxypropranolol, the major and active metabolite of propranolol

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    21. Harhangi, BS; Oostra, BA; Heutink, P; van Duijn, CM; Hofman, A; Breteler, MMB
      CYP2D6 polymorphism in Parkinson's disease: The Rotterdam study

      MOVEMENT DISORDERS
    22. Baltes, E; Coupez, R; Giezek, H; Voss, G; Meyerhoff, C; Benedetti, MS
      Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    23. Slanar, O; Perlik, F; Jirasek, V
      Phenotype of cytochrome P450CYP2D6 in patients with familial adenomatous polyposis

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    24. Ingelman-Sundberg, M
      Genetic variability in susceptibility and response to toxicants

      TOXICOLOGY LETTERS
    25. Ishii, M; Xu, BQ; Ding, LR; Fischer, NE; Inaba, T
      Interaction of plasma proteins with cytochromes P450 mediated metabolic reactions: inhibition by human serum albumin and alpha-globulins of the debrisoquine 4-hydroxylation (CYP2D) in liver microsomes of human, hamster and rat

      TOXICOLOGY LETTERS
    26. Olsson, B; Szamosi, J
      Multiple dose pharmacokinetics of a new once daily extended release tolterodine formulation versus immediate release tolterodine

      CLINICAL PHARMACOKINETICS
    27. Olsson, B; Szamosi, J
      Food does not influence the pharmacokinetics of a new extended release formulation of tolterodine for once daily treatment of patients with overactive bladder

      CLINICAL PHARMACOKINETICS
    28. Kvist, EE; Al-Shurbaji, A; Dahl, ML; Nordin, C; Alvan, G; Stahle, L
      Quantitative pharmacogenetics of nortriptyline - A novel approach

      CLINICAL PHARMACOKINETICS
    29. Pirmohamed, M
      Pharmacogenetics and pharmacogenomics

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    30. Scordo, MG; Aklillu, E; Yasar, U; Dahl, ML; Spina, E; Ingelman-Sundberg, M
      Genetic polymorphism of cytochrome P4502C9 in a Caucasian and a black African population

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    31. Roh, HK; Chung, JY; Oh, DY; Park, CS; Svensson, JO; Dahl, ML; Bertilsson, L
      Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    32. Yokono, A; Morita, S; Someya, T; Hirokane, G; Okawa, M; Shimoda, K
      The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    33. Eap, CB; Broly, F; Mino, A; Hammig, R; Deglon, JJ; Uehlinger, C; Meili, D; Chevalley, AF; Bertschy, G; Zullino, D; Kosel, M; Preisig, M; Baumann, P
      Cytochrome P450 2D6 genotype and methadone steady-state concentrations

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    34. Spina, E; Scordo, MG; Avenoso, A; Perucca, E
      Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    35. Teh, LK; Ismail, R; Yusoff, R; Hussein, A; Isa, MN; Rahman, ARA
      Heterogeneity of the CYP2D6 gene among Malays in Malaysia

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    36. Hayhurst, GP; Harlow, J; Chowdry, J; Gross, E; Hilton, E; Lennard, MS; Tucker, GT; Ellis, SW
      Influence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6

      BIOCHEMICAL JOURNAL
    37. Lam, LCW; Garcia-Barcelo, MM; Ungvari, GS; Tang, WK; Lam, VKL; Kwong, SL; Lau, BST; Kwong, PPK; Waye, MMY; Chiu, HFK
      Cytochrome P450 2D6 genotyping and association with tardive dyskinesia in Chinese schizophrenic patients

      PHARMACOPSYCHIATRY
    38. Llerena, A; Berecz, R; de la Rubia, A; Fernandez-Salguero, P; Dorado, P
      Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes

      THERAPEUTIC DRUG MONITORING
    39. Hussein, R; Charles, BG; Morris, RG; Rasiah, RL
      Population pharmacokinetics of perhexiline from very sparse, routine monitoring data

      THERAPEUTIC DRUG MONITORING
    40. Suzuki, Y; Someya, T; Shimoda, K; Hirokane, G; Morita, S; Yokono, A; Inoue, Y; Takahashi, S
      Importance of the cytochrome P450 2D6 genotype for the drug metabolic interaction between chlorpromazine and haloperidol

      THERAPEUTIC DRUG MONITORING
    41. Olsson, B; Landgren, BM
      The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrel

      CLINICAL THERAPEUTICS
    42. Ladona, MG; Izquierdo-Martinez, M; de la Paz, MP; de la Torre, R; Ampurdanes, C; Segura, J; Sanz, EJ
      Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome

      ENVIRONMENTAL HEALTH PERSPECTIVES
    43. Olsson, B; Brynne, N; Johansson, C; Arnberg, H
      Food increases the bioavailability of tolterodine but not effective exposure

      JOURNAL OF CLINICAL PHARMACOLOGY
    44. Chow, MSS; White, CM; Lau, CP; Fan, C; Tang, MO
      Evaluation of CYP2D6 oxidation of dextromethorphan and propafenone in a Chinese population with atrial fibrillation

      JOURNAL OF CLINICAL PHARMACOLOGY
    45. Barecki, ME; Casciano, CN; Johnson, WW; Clement, RP
      In vitro characterization of the inhibition profile of loratadine, desloratadine, and 3-OH-desloratadine for five human cytochrome P-450 enzymes

      DRUG METABOLISM AND DISPOSITION
    46. Andersson, TB; Sjoberg, H; Hoffmann, KJ; Boobis, AR; Watts, P; Edwards, RJ; Lake, BG; Price, RJ; Renwick, AB; Gomez-Lechon, MJ; Castell, JV; Ingelman-Sundberg, M; Hidestrand, M; Goldfarb, PS; Lewis, DFV; Corcos, L; Guillouzo, A; Taavitsainen, P; Pelkonen, O
      An assessment of human liver-derived in vitro systems to predict the in vivo metabolism and clearance of almokalant

      DRUG METABOLISM AND DISPOSITION
    47. Ingelman-Sundberg, M
      Implications of polymorphic cytochrome P450-dependent drug metabolism for drug development

      DRUG METABOLISM AND DISPOSITION
    48. Alvan, G; Bertilsson, L; Dahl, ML; Ingelman-Sundberg, M; Sjoqvist, F
      Moving toward genetic profiling in patient care: The scope and rationale of pharmacogenetic/ecogenetic investigation

      DRUG METABOLISM AND DISPOSITION
    49. Fang, J; Mckay, G; Song, JX; Remillrd, A; Li, XM; Midha, K
      In vitro characterization of the metabolism of haloperidol using recombinant cytochrome P450 enzymes and human liver microsomes

      DRUG METABOLISM AND DISPOSITION
    50. Murray, S; Odupitan, AOA; Murray, BP; Boobis, AR; Edwards, RJ
      Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline

      XENOBIOTICA
    51. Lohmann, PL; Rao, ML; Ludwig, M; Griese, EU; Zanger, UM; Morike, K; Maier, W; Bagli, M
      Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patients

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    52. Bergmann, TK; Bathum, L; Brosen, K
      Duplication of CYP2D6 predicts high clearance of desipramine but high clearance does not predict duplication of CYP2D6

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    53. Dandara, C; Masimirembwa, CM; Magimba, A; Sayi, J; Kaaya, S; Sommers, DK; Snyman, JR; Hasler, JA
      Genetic polymorphism of CYP2D6 and CYP2C19 in East- and Southern African populations including psychiatric patients

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    54. Agundez, JAG; Gallardo, L; Ledesma, MC; Lozano, L; Rodriguez-Lescure, A; Pontes, JC; Iglesias-Moreno, MC; Poch, J; Ladero, JM; Benitez, J
      Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients

      ONCOLOGY
    55. Payami, H; Lee, N; Zareparsi, S; McNeal, MG; Camicioli, R; Bird, TD; Sexton, G; Gancher, S; Kaye, J; Calhoun, D; Swanson, PD; Nutt, J
      Parkinson's disease, CYP2D6 polymorphism, and age

      NEUROLOGY
    56. Hanna, IH; Krauser, JA; Cai, HL; Kim, MS; Guengerich, FP
      Diversity in mechanisms of substrate oxidation by cytochrome P450 2D6 - Lack of an allosteric role of nadph-cytochrome P450 reductase in catalytic regioselectivity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    57. Chew, M; White, JM; Somogyi, AA; Bochner, F; Irvine, RJ
      Precipitated withdrawal following codeine administration is dependent on CYP genotype

      EUROPEAN JOURNAL OF PHARMACOLOGY
    58. Hiroi, T; Kishimoto, W; Chow, T; Imaoka, S; Igarashi, TS; Funae, Y
      Progesterone oxidation by cytochrome P450 2D isoforms in the brain

      ENDOCRINOLOGY
    59. Cepeda, MS; Farrar, JT; Roa, JH; Boston, R; Meng, QC; Ruiz, F; Carr, DB; Strom, BL
      Ethnicity influences morphine pharmacokinetics and pharmacodynamics

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    60. Zimova, G; Chladek, J; Martinkova, J; Beranek, M
      HPLC determination of dextromethorphan and its metabolites in plasma

      CHEMICKE LISTY
    61. Williams, DG; Hatch, DJ; Howard, RF
      Codeine phosphate in paediatric medicine

      BRITISH JOURNAL OF ANAESTHESIA
    62. Kalow, W
      Perspectives in pharmacogenetics

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    63. Deeni, YY; Paine, MJI; Ayrton, AD; Clarke, SE; Chenery, R; Wolf, CR
      Expression, purification, and biochemical characterization of a human cytochrome P450CYP2D6-NADPH cytochrome P450 reductase fusion protein

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    64. Hanna, IH; Kim, MS; Guengerich, FP
      Heterologous expression of cytochrome P450 2D6 mutants, electron transfer,and catalysis of bufuralol hydroxylation: The role of aspartate 301 in structural integrity

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    65. Vaughan, JR; Davis, MB; Wood, NW
      Genetics of Parkinsonism: a review

      ANNALS OF HUMAN GENETICS
    66. Nakamura, K; Hanna, IH; Cai, HL; Nishimura, Y; Williams, KM; Guengerich, FP
      Coumarin substrates for cytochrome P450 2D6 fluorescence assays

      ANALYTICAL BIOCHEMISTRY
    67. Kirchheiner, J; Brosen, K; Dahl, ML; Gram, LF; Kasper, S; Roots, I; Sjoqvist, F; Spina, E; Brockmoller, J
      CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages

      ACTA PSYCHIATRICA SCANDINAVICA
    68. Zhou, HH; Liu, ZO
      Ethnic differences in drug metabolism

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    69. Cerqueira, PM; Mateus, FH; Cesarino, EJ; Bonato, PS; Lanchote, VL
      Enantioselectivity of debrisoquine 4-hydroxylation in Brazilian Caucasian hypertensive patients phenotyped as extensive metabolizers

      JOURNAL OF CHROMATOGRAPHY B
    70. Oka, T; Fukuhara, M; Ushio, F; Kurose, K
      Molecular cloning and characterization of three novel cytochrome P450 2D isoforms, CYP2D20, CYP2D27, and CYP2D28 in the Syrian hamster (Mesocricetus auratus)

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY
    71. Roberts, R; Sullivan, P; Joyce, P; Kennedy, MA
      Rapid and comprehensive determination of cytochrome P450CYP2D6 poor metabolizer genotypes by multiplex polymerase chain reaction

      HUMAN MUTATION
    72. Clark, D; Morgan, A; Hananeia, L; Coulter, D; Olds, R
      Drug metabolism genotypes and their association with adverse drug reactions in selected populations: a pilot study of methodology

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    73. Eap, CB
      On the usefulness of therapeutic drug monitoring of methadone

      EUROPEAN ADDICTION RESEARCH
    74. Raimundo, S; Fischer, R; Eichelbaum, M; Griese, EU; Schwab, M; Zanger, UM
      Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6

      PHARMACOGENETICS
    75. Murphy, MP; Beaman, ME; Clark, LS; Cayouette, M; Benson, L; Morris, DM; Polli, JW
      Prospective GYP2D6 genotyping as an exclusion criterion for enrollment of a phase III clinical trial

      PHARMACOGENETICS
    76. Nishida, Y; Fukuda, T; Yamamoto, I; Azuma, J
      CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10

      PHARMACOGENETICS
    77. Marcus, PM; Vineis, P; Rothman, N
      NAT2 slow acetylation and bladder cancer risk: a metaanalysis of 22 case-control studies conducted in the general population

      PHARMACOGENETICS
    78. Saarikoski, ST; Sata, F; Husgafvel-Pursiainen, K; Rautalahti, M; Haukka, J; Impivaara, O; Jarvisalo, J; Vainio, H; Hirvonen, A
      CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour

      PHARMACOGENETICS
    79. Laforest, L; Wikman, H; Benhamou, S; Saarikoski, ST; Bouchardy, C; Hirvonen, A; Dayer, P; Husgafvel-Pursiainen, K
      CYP2D6 gene polymorphism in Caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships

      EUROPEAN JOURNAL OF CANCER
    80. Gaedigk, A
      Interethnic differences of drug-metabolizing enzymes

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    81. Venhorst, J; Onderwater, RCA; Meerman, JHN; Vermeulen, NPE; Commandeur, JNM
      Evaluation of a novel high-throughput assay for cytochrome P450 2D6 using 7-methoxy-4-(aminomethyl)-coumarin

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    82. Hiratsuka, M; Agatsuma, Y; Omori, F; Narahara, K; Inoue, T; Kishikawa, Y; Mizugaki, M
      High throughput detection of drug-metabolizing enzyme polymorphisms by allele-specific fluorogenic 5 ' nuclease chain reaction assay

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    83. Shimoda, K; Morita, S; Hirokane, G; Yokono, A; Someya, T; Takahashi, S
      Metabolism of desipramine in Japanese psychiatric patients: The impact of CYP2D6 genotype on the hydroxylation of desipramine

      PHARMACOLOGY & TOXICOLOGY
    84. Jurima-Romet, M; Casley, WL; Leblanc, CA; Nowakowska, M
      Evidence for the catalysis of dextromethorphan O-demethylation by a CYP2D6-like enzyme in pig liver

      TOXICOLOGY IN VITRO
    85. Zelenkav, O; Hadsova, E; Ceskova, E; Vojtiskova, M; Hyksova, M
      Effects of psychopharmacotherapy on phenotypic expression of cytochrome P450 2D6 in patients genotyped for CYP2D6 mutations

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    86. March, R
      Pharmacogenomics: the genomics of drug response

      YEAST
    87. Bernard, SA; Bruera, E
      Drug interactions in palliative care

      JOURNAL OF CLINICAL ONCOLOGY
    88. Isaza, CA; Henao, J; Lopez, AM; Cacabelos, R
      Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    89. Eap, CB; Bourquin, M; Martin, JL; Spagnoli, J; Livoti, S; Powell, K; Baumann, P; Deglon, JJ
      Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment

      DRUG AND ALCOHOL DEPENDENCE
    90. Wilcox, RA; Owen, H
      Variable cytochrome P450 2D6 expression and metabolism of codeine and other opioid prodrugs: Implications for the Australian anaesthetist

      ANAESTHESIA AND INTENSIVE CARE
    91. Somer, M; Kallio, J; Pesonen, U; Pyykko, K; Huupponen, R; Scheinin, M
      Influence of hydroxychloroquine on the bioavailability of oral metoprolol

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    92. Abraham, BK; Adithan, C; Shashindran, CH; Vasu, S; Alekutty, NA
      Genetic polymorphism of CYP2D6 in a Keralite (South India) population

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    93. Dalen, P; Dahl, ML; Andersson, K; Bertilsson, L
      Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genes

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    94. Smith, AJ
      Quality use of medicines: Where does Pharmacology 'end'? Invited ascept lecture

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    95. Fukuda, R
      Factors affecting serum haloperidol level assessed by longitudinal therapeutic monitoring

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    96. Kathiramalainathan, K; Kaplan, HL; Romach, MK; Busto, UE; Li, NY; Sawe, J; Tyndale, RF; Sellers, EM
      Inhibition of cytochrome P450 2D6 modifies codeine abuse liability

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    97. Morita, S; Shimoda, K; Someya, T; Yoshimura, Y; Kamijima, K; Kato, N
      Steady-state plasma levels of nortriptyline and its hydroxylated metabolites in Japanese patients: Impact of CYP2D6 genotype on the hydroxylation of nortriptyline

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    98. Chou, WH; Yan, FX; de Leon, J; Barnhill, J; Rogers, T; Cronin, M; Pho, M; Xiao, V; Ryder, TB; Liu, WW; Teiling, C; Wedlund, PJ
      Extension of a pilot study: Impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    99. Ismail, R; Hussein, A; Teh, LK; Isa, MN
      CYP2D6 phenotypes among Malays in Malaysia

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    100. Poolsup, N; Po, ALW; Knight, TL
      Pharmacogenetics and psychopharmacotherapy

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 12:36:41